STUDY QUESTION: Can a discriminant threshold be determined for human sperm DNA oxidation?
Introduction
Oxidative stress (OS) is the major contributing cause of damage to sperm DNA (Aitken, 1994; Lewis et al., 1995; Fisher and Aitken, 1997; Irvine et al., 2000; Aitken et al., 2012 Aitken et al., , 2014 ). An early marker of DNA oxidation is the formation of base adducts such as 8-hydroxy-2'-deoxyguanosine (8-OHdG) . DNA oxidation triggers activation of the base excision repair pathway (BER), which eliminates oxidized residues, such as 8-OHdG, via the 8-oxoguanine glycosylase 1 (OGG1) enzyme, and inserts a new nucleotide on free 3'-OH ends using the APE1 protein (Smith et al., 2013) . APE1 is not present in human spermatozoa, making it impossible to complete the BER pathway, which remains halted at the generation of an abasic site (Hoeijmakers, 2001; Smith et al., 2013) . However, the oocyte does possess APE1 and XRCC1, permitting continuation of the BER pathway and effective DNA repair following fertilization (Lord and Aitken, 2015) . Since the oocyte is deficient in OGG1 (Wood et al., 1992; Lord and Aitken, 2015) , non-resolution of sperm DNA 8-OHdG adducts means they will persist in the zygote and create the opportunity for mutations to occur (typically transversion mutations) prior to the initiation of embryonic development (Wood et al., 1992; Lord and Aitken, 2015) . Consistent with this situation, it has been reported that high sperm DNA oxidation can impair the oocyte's ability to activate a normal developmental program (Morado et al., 2013; Park et al., 2015) . In this context, assessment of sperm DNA oxidation should be of interest to manage male factor infertility associated with OS.
A limited number of reports have shown that 8-OHdG levels are negatively correlated with male fecundity (Fraga et al., 1991; Loft et al., 2003; Lewis and Aitken, 2005 ) and sperm quality (Cambi et al., 2013) . However, others have found no correlation between oxidative DNA alterations and semen parameters Montjean et al., 2010; Zribi et al., 2011) . These discrepancies underpin the lack of consensus regarding the predictive utility of such evaluations and stem from differences in several parameters including: the type of assays used to evaluate DNA oxidation, operator bias, variable patient selection criteria and the sperm isolation protocols used. The literature reveals several methods to detect sperm DNA oxidation, particularly the detection of 8-OHdG residues. Recently, the specificity and reliability of commercially available kits for the detection of human sperm DNA 8-OHdG residues have been questioned (Cambi et al., 2013) revealing the lack of a proper and reliable tool to evaluate sperm DNA oxidation. The aims of this study were to validate a standardized protocol using specific 8-OHdG immuno-detection, compare its accuracy with the commercial OxyDNA Test ® and examine its output in relation to various parameters of sperm quality. The assay we have developed has allowed us to propose a discriminant threshold of human sperm DNA oxidation that should find application in the diagnosis of male factor infertility associated with OS. 
Material and Methods

Patient samples and ethics statement
Experimental design
The experimental design is described in Fig. 1 and Supplementary Fig. S1 . In the first set of experiments, we carried out an intra-methods comparison between three methods of detection (pairwise) using the same anti-8-OHdG primary antibody and light microscopy (LM, protocol I), fluorescence microscopy (FM, protocol II) and flow cytometry (FCM, protocol III). In the second set of experiments, we assessed the reliability of values obtained with protocol III and those obtained with the OxyDNA Test ® (protocol IV).
Using FCM for both protocols III and IV, the percentage of 8-OHdGpositive spermatozoa and the mean intensity level of fluorescence (MIF) were evaluated.
8-OHdG detection
For all four conditions, PBS-washed samples were incubated for 10 min in the dark in a decondensation buffer comprising 2 mM dithiothreitol (DTT), 0.5% Triton X-100 and 1× PBS, as previously described (Noblanc et al., 2012) , followed by fixation with 4% paraformaldehyde. For protocols I, II and III, spermatozoa were incubated in 1.5% normal goat serum saturation solution. Incubations with anti-8-OHdG monoclonal antibody (1:1000) and secondary (1:500 and 1:1000 for IgG-coupled [HRP] and Alexa Fluor 488, respectively) antibodies were conducted overnight and for 90 min, respectively. For protocol I, peroxidase signal detection was achieved using the Vector Nova Red substrate kit. For both protocols I and II each sample was spread on two Super Frost ® slides and the slides were read 'blind' by two different observers. Spermatozoa were considered as 8-OHdGpositive when a spot of peroxidase (pink-brown color) or green fluorescence was observed ( Supplementary Fig. S1 ). In protocol IV, the OxyDNA Test ® was used per the manufacturer's indications. For each assay, control incubations were conducted comprising a negative control untreated with anti-8-OHdG primary antibody or the binding conjugate, and a positive control treated with an 8 M H 2 O 2 solution for 1 h before fixation. The specificity and sensitivity of protocols III and IV were controlled (n = 3) by pre-incubating anti-8-OHdG antibody or FITC-conjugate with increasing concentrations of exogenous 8-OHdG or 3-dG (negative control) for 3 h. To measure signal stability as a function of time, spermatozoa underwent fixation and were then stored in a 0.01% sodium azide/PBS solution for 0, 15 and 30 days before final labeling. An analysis was then performed to compare any changes in oxidized sperm percentage and MIF. Tests of intra-and inter-assay repeatability were also performed to determine coefficient of variation (CV) using five sperm samples assayed in triplicate (intra-assay CV) on three different days (inter-assay CV). Analyses of Protocols III and IV were performed on a BD FACS Aria SORP (BD Biosciences, Franklin Lakes, NJ, USA) cell sorter using an 85 μm nozzle. The forward-scattered light and side-scattered light were detected on a linear scale and used to gate sperm cells. Sperm cell gating was confirmed by microscopy after cell sorting. Cytometry detection using protocol IV differentiated two subpopulations ( Supplementary Fig. S1 ). Throughout this work, we have considered both the total fluorescent sperm population termed 'IV population' and the subpopulation with the highest MIF termed 'HF IV' (HF for highly fluorescent). (Cohen, 1998) . Receiver operating characteristic (ROC) curve analyses were performed using AUC and 95% CI. Then, the optimal threshold to predict a pathological state was determined according to biological and clinical relevance and according to usual indexes recommended in the literature These usual inferential analyses were followed by factorial analysis: principal component analysis (PCA) used to study relationships between quantitative parameters, and factor discriminant analysis (FDA). Statistical analysis details are described in Supplementary Data.
Statistical analysis
Results
Intra-methods and inter-methods comparisons
Protocols I (LM) and II (FM) were moderately, but significantly concordant with a Bland-Altman bias of measure of 4.7 [−36.51 to 45.84] ( Table I) . Protocols II and III (FCM) were both significantly and substantially positively correlated (P = 0.004) and concordant (κ LIN = 0.66, P < 0.001) with a Bland-Altman bias of 2.4 [−26.66-31 .34] which was highly reliable giving comparable values for the proportion of 8-OHdG-positive spermatozoa, for both subjects and positive controls.
The mean percentage of 8-OHdG-positive spermatozoa labeled with protocol IV was significantly higher than with protocol III (84.9% vs. 66.6% P < 0.001, Table I ) and very weakly concordant (κ LIN = 0.28, P < 0.001, Bland-Altman bias of −17.6 [−61.4-26.1]) and correlated (r = 0.41, P = 0.0002). MIF values were not significantly different, but the two methods were neither significantly correlated nor concordant between themselves: 830 vs. 937 arbitrary units (a.u.) for protocols IV and III, respectively (Table I) . Flow cytometry detection using Step 1 : Intra-methods validation using anti-8-OHdG antibody 15A3 clone
Step 2 Intra-methods and inter-method validations were determined by comparing pairwise protocols I vs. II (n = 10), protocols II vs. III (n = 15), and protocols III vs. IV (n = 80) by considering for subjects and controls: statistical difference using parametric (Student's t-test) or non-parametric (Wilcoxon test) paired tests according to statistical distribution and number of subjects; Statistical concordance using Lin's concordance coefficient (Kappa LIN) and Bland-Altman test (Bland and Altman Bias) . Kappa LIN values are usually framed in a scheme where <0.20 is negligible, 0.21-0.40 weak, 0.41-0.6 moderate, 0.61-0.8 substantial and >0.8 excellent concordance. The Bland-Altman test measured the difference between the two methods, also called 'bias of measure'; Pearson or Spearman correlations (r) according to statistical distribution and number of subjects. Values are mean ± SEM for percentage (%) of 8-hydroxy-2'-deoxyguanosine-positive spermatozoa (8-OHdG spz) and the mean intensity of fluorescence (MIF) using arbitrary units (a.u.) with agreement limits corresponding to 95% CI. *, **, *** indicate significant difference.
protocol IV distinguished two populations with different fluorescent intensity profiles ( Supplementary Fig. S1 ). Comparison of only the highly fluorescent (HF) subpopulation revealed the protocol IV values were also neither significantly concordant (κ LIN = 0.051, P = 0.515) nor correlated (r = 0.074, P = 0.516) with protocol III, with a very high bias of 23.6% [−44 to 91.3] . These results were confirmed by the individual distribution profiles ( Supplementary Fig. S2 ) showing no similarity in the staining profiles of protocols III and IV. This was notable for the 8-OHdG-positive sperm percentage. The discordance between the three profiles suggests that protocols III and IV did not detect the same target in the human sperm nucleus. Competition experiments with exogenous 8-OHdG and 3-dG confirmed this hypothesis (Supplementary Fig. S3 ). Indeed, we observed a significant and dose-dependent shift in the percentage of 8-OHdGpositive cells detected using protocol III when pre-incubation with exogenous 8-OHdG was performed (from 83.6% for the basal condition to 39.7% when 2.5 μmol of competitor was employed P < 0.001, Supplementary Fig. S3 ). On the contrary, there was no change to the 8-OHdG-positive percentages when an identical competition was carried out with protocol IV. Although MIF values were decreased for both protocols, the measured effects were not statistically significant due to inter-individual variability (P = 0.14 and P = 0.74 for protocols III and IV, respectively). In contrast, when pre-incubation was carried out with an unrelated 3-dG residue we observed no impact on either the percentage or on the MIF in either protocol III or IV. These results highlighted the higher sensitivity and specificity of protocol III compared with protocol IV for the detection of human sperm 8-OHdG residues.
Correlative analyses and reliability of 8-OHdG levels with sperm and clinical parameters Using protocol III, a significant positive correlation was observed between MIF and BMI (r = 0.6, P < 0.001, Table II) as overweight patients showed a significantly higher MIF compared with the normalweight group (P < 0.01, Table II ). The MIF showed a significant positive correlation with round cell concentration (r = 0.26, P < 0.05 Table II and PCA, Supplementary Fig. S3B , sperm concentration (r = 0.25, P < 0.05) and polymorphonuclear neutrophil cell (PMN) concentration (r = 0.5, P < 0.001). Furthermore, we revealed significant differences in 8-OHdG + spermatozoa percentage and/or MIF for all sperm parameters investigated, i.e. necrozoospermia (P < 0.05), asthenozoospermia (P < 0.01), teratozoospermia (P < 0.05) and leukocytospermia (P < 0.001) subjects in comparison with respective control groups (Table II) . The highest ES was observed for leukocytospermia subjects with a value of 1.82 [1.12; 2.52] in comparison with subjects with a normal seminal PMN concentration (Table II) . When subjects with altered sperm parameters (irrespective of the alteration) were compared to normozoospermic subjects, a significant difference in MIF was also seen with an ES = 0.6 ([0.15; 1.05], P < 0.01). We did not determine any significant difference between fecund or infecund subject groups regarding percentage (P = 0.75) or MIF (P = 0.26). Using protocol IV, neither the 8-OHdG spermatozoa percentage nor the MIF showed any significant correlation with sperm parameters, fecundity or clinical data (Table II and PCA analysis: Supplementary Fig. S3B ).
ROC curve analysis was used to determine the empirical optimal cut point in relation to sperm parameters. With regard to protocol III, optimal cut-off points of 65.8% for 8-OHdG-positive sperm with a MIF of 552 a.u. were determined, with an AUC of 0.62 ([0.49; 0.74] ; sensitivity = 0.54; specificity = 0.72, Fig. 2A ) and 0.57 ([0.44; 0.70] ; sensitivity = 0.72; specificity = 0.46) for MIF and percentage, respectively. Using this threshold, we clearly distinguished two major subpopulations within the value distributions presented (Fig. 2B) : in the first, 23 subjects had DNA sperm oxidation values higher than the cut-off (light gray area surrounded by a red line box), 61% possessed altered sperm parameters, notably leukocytospermia (71%); in the second, 47 subjects had a MIF below or equal to 552 a.u., regardless of the positive spermatozoa proportion (dark gray area surrounded by a blue line), 40% presented with altered sperm parameters and of these 89% had teratozoospermia. Only two patients exhibited leukocytospermia. It follows that 39% of the subjects with 'pathological' sperm DNA oxidation were otherwise normozoospermic.
With regard to protocol IV, ROC analysis allowed us to determine an empirical threshold for MIF and percentage of 758 a.u. and 84.4%, respectively, but their AUC were not correct. Moreover, the value distribution analysis (Fig. 2C ) did not reveal any significant discrimination regarding global sperm alteration.
The protocol III thresholds determined for 8-OHdG and MIF were particularly discriminating with regard to PMN concentration and leukocytospermia as shown by the high sensitivity (0.86) and specificity (0.79) of the ROC curve (AUC = 0.87 [0.76; 0.99], Fig. 3A ) and the factorial discriminant analysis (FDA, Fig. 3B and C) . Indeed, we observed that each subject represented by a point in FDA was discriminated satisfactorily according to PMN concentration, clearly distinguishing two populations. This was not the case for protocol IV, with respect to either the total or the HF population (FDA representations show all the points gathered at the center of Fig. 3C ).
Stability and repeatability assays
To determine signal stability over the time, fixed spermatozoa were stored in 0.01% sodium azide solution in PBS for 0, 15 and 30 days before labeling. With protocol III, the first significant alteration to MIF and oxidized sperm proportions appeared after 30 days of storage for both subject samples and positive controls ( Supplementary Fig. S4A and B). With protocol IV, a significant increase was observed for the oxidized sperm proportion from Day 15 for the positive controls (P < 0.05 Supplementary Fig. S4C ). Finally, intra-and inter-assay CVs (Supplementary Table SI) were determined using protocol III. The CVs were less than or equal to 7.5% for both percentage and MIF values for patients and H 2 O 2 control values, indicating an acceptable repeatability for diagnostic use.
Discussion
Protocols I, II and III showed consistent reliability. However, several practical characteristics concerning protocols I and II render them difficult for continued diagnostic application. Peroxidase detection coupled with light microscopy is time-consuming, has a long learning curve, and observers must be experienced in order to read 8-OHdG sperm labeling in a consistent manner without introducing inter-operator variability. Detection by FCM in protocol III is impartial and enables evaluation of a large number of cells over a short period of time.
Our study shows a relatively high percentage of positive sperm cells identified by all the protocols when compared with previously reported observations (Meseguer et al., 2008; Zribi et al., 2010 Zribi et al., , 2011 Cambi et al., 2013) . The DNA decondensation pretreatment could partly explain this situation, by increasing antibody access to DNA 8-OHdG sites. This step was optimized in order to ensure access of the anti-8-OHdG antibody and OxyDNA conjugate to most sites of DNA oxidation in sperm chromatin with the goal of obtaining the best signal with the lowest concentration of antibody or conjugate (data not shown). We also reduced the time of decondensation to 10 min with 2 mM DTT to preserve head morphology without seeing a significant difference in labeling in comparison with the 45-min incubation currently used (Twigg et al., 1998; De Iuliis et al., 2009; Muratori et al., 2015) .
Moreover, we defined 8-OHdG positivity as any spermatozoa with a spot of fluorescence rather than previous methods that defined positivity when over 50% of the head was stained (Park et al., 2015) . This was adopted to give the most sensitive indication of oxidative damage and to derive an objective threshold value for determining correlations with sperm quality. In a similar manner, the 8 M H 2 O 2 pretreatment was selected for the positive control after comparison with different published oxidative conditions including various concentrations of H 2 O 2 (25 μM (Cambi et al., 2013) , 5 mM (Santiso et al., 2010) , 4 M (Zribi et al., 2011) ; Fenton chemistry Micillo et al., 2016) ; or, pesticide-mediated endocrine disruption (Bagchi et al., 1995; Grizard et al., 2007) ). To the best of our knowledge, no previous studies have tested 8 M H 2 O 2 pretreatment, however we found that 8 M H 2 O 2 (1 h, at room temperature, in the dark) provided the most consistent intraand inter-CV on both the 8-OHdG-positive sperm percentage and MIF (2.2% and 6.9%, respectively for protocol III) regardless of the initial sperm sample quality and/or protocol. As shown ( Supplementary  Fig. S1 ) on visible or epifluorescence photographs, or on FCM histograms, sperm morphology was conserved in these conditions. Moreover, in order to verify nuclei structure integrity, in few experimentation sperm cells were countermarked using Hoechst and observed using confocal microscope. The fact that the treatment is performed on raw semen samples may also partly explain why such a high concentration of H 2 O 2 had to be used for the positive controls.
The competition assay using the OxyDNA Test® (protocol IV) and high level of exogenous 8-OhdG revealed the test's poor sensitivity Relationship between sperm DNA oxidation and clinical and sperm parameters were measured using Spearman correlations (r), parametric or non-parametric tests according to statistical distribution and number of subjects (n) and the effect-size determination. Data are presented as the mean ± SEM with agreement limits corresponding to 95% CI.*, **, *** indicate significant difference with P < 0.05, P < 0.01 and P < 0.001 in comparison with respective normal groups. Numbers in bold characters are statistically significant.
and specificity, whereas a significant and dose-dependent shift was observed with protocol III. Similar results were reported earlier by Cambi et al. (2013) , raising the question of the pertinence of the OxyDNA assay's conjugate for DNA 8-OHdG. Moreover, neither the 8-OHdG spermatozoa percentage nor the MIF determined using protocol IV showed any significant correlation with clinical endpoints, patient fertility or sperm quality. Therefore, data from the competition assay, similar to the stability and repeatability assays, demonstrated the superiority and the accuracy of protocol III to detect human sperm 8-OHdG. Using protocol III, we observed significant correlations between sperm DNA oxidation and alterations in sperm parameters. Most notable was the positive correlation between MIF, PMN concentration and BMI, consistent with inflammatory and oxidative states. Even though this was expected since PMN are known to be a major source of reactive oxygen species in semen, our data clearly confirm that sperm DNA oxidation is related to a high PMN concentration. Previous studies have already reported relationships between sperm DNA oxidation and isolated sperm parameters including sperm concentration (Kodama et al., 1997; Ni et al., 1997; Park et al., 2015; Micillo et al., 2016) , sperm motility Kao et al., 2008; Meseguer et al., 2008; Chen et al., 2012; Cambi et al., 2013) or sperm morphology (Cambi et al., 2013) . In Meseguer et al. (2008) a correlation between asthenozoospermia and oxidative stress was found when using both the average 8-OHdG signal intensity and the percentage of positive cells, but the authors did not propose a threshold. We are the first to propose thresholds for the percentage of 8-OHdGpositive cells and the average intensity of the signal generated per cell. Optimal cut-off points of 65.8% for 8-OHdG-positive sperm with a MIF of 552 a.u. were determined, with AUC of 0.62 and 0.57 for MIF and percentage, respectively. Even if AUC were moderate, MIF and percentage values were complementary to each other, MIF bringing a good specificity (0.72) and the percentage a good sensitivity (0.72). Of interest was the observation that 39% of the subjects with what we could define as 'pathological' sperm DNA oxidation were otherwise normozoospermic. This suggests that motile, fertile spermatozoa could still possess high levels of oxidative DNA damage. It is also worth noting that some leukocytospermic patients did show a normal DNA oxidation value and conversely others with oxidized sperm DNA showed a normal PMN concentration revealing inter-individual variation. Consequently, human sperm DNA 8-OHdG detection should not be seen as a unique definitive marker of sperm DNA integrity. It should be used in combination with conventional sperm quality indicators such as those included in the WHO standardized checklist together with a sperm DNA fragmentation assay. Indeed, base oxidation is a precocious indicator of DNA oxidative damage. Depending on the level of oxidative stress it may or may not be associated with sperm nuclear decondensation and fragmentation conditions that have in turn been associated with male infertility. Regardless, an oxidized sperm nucleus will challenge the oocyte BER pathway, which may result in an increase in the mutational load subsequently carried by the offspring (Aitken, 1999; Crow, 2000; Baker and Aitken, 2005) . In our technical validation study we did not observe significant correlation between sperm DNA oxidation and male fecundity. However, having a child is not a presage of current sperm quality or the absence of transgenerational impact. Other parameters come into play in accomplishing a pregnancy including the oocyte's repair power. In order to investigate these aspects, complementary investigations are now necessary and should focus on deciphering the relationship existing between sperm DNA oxidation and it's impact on embryo development and the offspring's future health.
Conclusion
Our study is the first validation of a protocol to assess human sperm DNA oxidation levels using the anti-8-OHdG antibody and FCM to determine an associated discriminant threshold in relation to sperm quality. We have demonstrated the protocol accuracy with regard to 8-OHdG detection in human sperm. The stability over time (up to 30 days) and good intra-and inter-assay CV provide additional, supporting arguments for potential practical routine diagnostic use. In addition, this test could be a helpful decision-making tool regarding whether or not to pursue therapeutic intervention such as the use of oral antioxidant supplementation. Since over-supplementation of antioxidants could exacerbate sperm DNA decondensation (Agarwal and Allamaneni, 2004; Greco et al., 2005; Ménézo et al., 2007; Lanzafame et al., 2009; Ross et al., 2010; Gharagozloo and Aitken, 2011; Showell et al., 2014) it is critical to know when to apply such therapeutic intervention. However, when antioxidant use is relevant, it may improve live birth rates and increase clinical pregnancy rates, as suggested by the Cochrane review (Showell et al., 2014) . Therefore, a reliable, accurate and sensitive human sperm DNA 8-OHdG detection assay, such as the one described here, could be a pertinent addition to the andrology clinician's toolbox.
Supplementary data
Supplementary data are available at Human Reproduction online. Figure 3 Discrimination related to polymorphonuclear neutrophil cell concentration. A: ROC curve illustrating the relationship between MIF determined using protocol III and polymorphonuclear neutrophil cell (PMN) concentration. B and C: factor discriminant analysis representing MIF values obtained using protocol III (B) or IV (C, IV for total population and HF IV for HF subpopulation) according to whether the subject has a normal PMN concentration (group 1) or is leukocytospermic (group 2). IV population: total fluorescent sperm population. HF IV: subpopulation with the highest fluorescence intensity mean termed (HF: highly fluorescent).
